预期性发作焦虑:什么是最好的治疗方法?
Coraline Hingray1,2,3, Herve Javelot2,4, Frank Lach2,4
1EEG-monitoring Unit, Neurology Department, Hôpital Central, CHU de Nancy, 54000 Nancy, France.
Epilepsy & behavior reports
|June 6, 2024
概括
预期性发作焦虑 (AAS) 在患者中很常见,影响生活质量. 这项案例研究表明,塞特拉林或奇塔洛普拉姆是PWE中AAS的有效一线治疗方法.
科学领域:
- 神经学 神经学
- 精神病学是一个精神病学.
- 临床医学 临床医学
背景情况:
- 焦虑障碍影响了大约25%的患者 (PWE).
- 预期性发作焦虑 (AAS) 是一种常见的亚型,其特点是对未来的发作持久地担心,并经常导致回避行为.
- AAS经常被忽视和治疗不足,对PWE患者的生活质量和管理产生负面影响.
研究的目的:
- 为了呈现出焦点的次要AAS病例.
- 提供实用指南和工具,用于查和治疗PWE中的焦虑障碍.
- 评估潜在的精神药物用于AAS管理.
主要方法:
- 一个35岁的焦点和AAS患者的病例报告.
- 关于中焦虑障碍的当前文献的综述.
- 对AAS的药理治疗选择的讨论.
主要成果:
- 该案例强调了在PWE中诊断和管理AAS的挑战.
- 塞特拉林和西塔洛普拉姆被确定为AAS的潜在有效的第一线治疗方法.
- 这些SSRI在患者中表现出良好的耐受性.
结论:
- 在患有的人中,AAS是一个重要的关注点,需要临床关注.
- 早期查和适当的治疗,包括像塞特拉林或西塔洛普拉姆这样的SSRI,可以改善PWE与AAS的结果.
- 对中AAS的最佳管理策略进行进一步的研究是有必要的.
相关概念视频
Anxiolytic Drugs: Overview
272
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
272
Antiepileptic Drugs: Glutamate Antagonists
320
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
320
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
286
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
286
Antiepileptic Drugs: Sodium Channel Blockers
511
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
511
Anxiolytic Drugs: Benzodiazepines and Buspirone
679
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
679
Antiepileptic Drugs: GABAergic Pathway Potentiators
385
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
385


